Provided by Tiger Trade Technology Pte. Ltd.

Biogen

225.88
-1.1900-0.52%
Post-market: 225.880.00000.00%19:30 EDT
Volume:1.55M
Turnover:352.50M
Market Cap:33.35B
PE:40.12
High:229.36
Open:227.23
Low:225.51
Close:227.07
52wk High:230.49
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.30
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.77
PE(LYR):25.70

Loading ...

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

TIPRANKS
·
Aug 22

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Reuters
·
Aug 20

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

TIPRANKS
·
Aug 14

Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300

MT Newswires Live
·
Aug 13

Barclays Keeps Their Hold Rating on Biogen (BIIB)

TIPRANKS
·
Aug 13

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Reuters
·
Aug 13

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Kailera Therapeutics Names Nur Nicholson Chief Technology Officer

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors?

Simply Wall St.
·
Aug 09

Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab

TIPRANKS
·
Aug 08

Biogen completes acquisition of RayThera

TIPRANKS
·
Aug 07

Biogen Completes Acquisition of RayThera

Reuters
·
Aug 07

Biogen Completes Acquisition of Raythera Inc.

THOMSON REUTERS
·
Aug 07